Abstract: The disclosure relates to methods and compositions for the treatment of Systemic Lupus Erythematosus (SLE). The disclosure particular relates to the treatment of flares in SLE across multiple organ domains.

Abstract: A security system for shipped medical products or research tools includes a container with a least one closable opening. A closure mechanism positionable to seal the closable opening. The closure mechanism can have multiple touch zones, with each of the multiple touch zones providing a distinguishable electric signal. An electronic controller is attachable to the multiple touch zones of the closure mechanism and able to store and transmit a sequence of touches, with at least one sequence of touches indicating authorization for opening the container after removal of the closure mechanism.

Abstract: A method for providing medical services and collecting and monitoring patient data includes taking an image of a patient face and determining position of facial and hair features including eyes and eyebrows. The eyes are masked and the patient is asked to verify that the eyes are masked in order to maintain HIPAA compliance. A health management system with an associated machine learning system can be used to identify facial and hair abnormalities, including rashes and alopecia.

Abstract: The disclosure relates to methods and compositions for the treatment of Systemic Lupus Erythematosus (SLE). Specifically, the disclosure relates to methods comprising administering to a subject a type I IFN receptor inhibitor.